CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Claforan In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Claforan In Dextrose 5% In Plastic Container launch?
Claforan In Dextrose 5% In Plastic Container is a drug marketed by Sterimax and is included in one NDA.
The generic ingredient in CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Håkan Hanberger | Phase 4 |
University Medical Center Groningen | Phase 4 |
University of California, San Francisco | Phase 1 |
See all CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents and Regulatory Information for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sterimax | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050596-002 | May 20, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sterimax | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050596-004 | May 20, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |